Wednesday, April 27, 2016

BRIEF-Immune Therapeutics says NAFDAC approves Lodonal

* NAFDAC approved lodonal as over counter, non-toxic adjunct

therapy in treatment of HIV/Aids and immune system regulator

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom; +1 646 223 8780; )

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)